Azala

Advance in the Treatment of Pediatric Leukemia

The book gives an overview on the progress that has been made in the treatment of acute lymphoblastic leukemia (ALL), of acute and chronic myeloid leukemia (AML, CML) and of juvenile myelomonocytic leukemia (JMML). Leukemia is the most common malignant disease in children, and 80% of patients are di...

Deskribapen osoa

Gorde:
Formatua: Online
Hizkuntza:ingelesa
Argitaratua: MDPI - Multidisciplinary Digital Publishing Institute 2022
Gaiak:
acute lymphoblastic leukemia
pediatric
advances
diagnosis
treatment
immunotherapy
bispecific T-cell engager (BiTE)
BCP-ALL
leukemia
TRAIL
antibody
Fc-engineering
xenograft
CD19
juvenile myelomonocytic leukemia
RAS signaling
hematopoietic stem cell transplantation
5-azacitidine
myelodysplastic/myeloproliferative disorders
targeted therapy
ADC
antibody–drug conjugate
pediatric leukemia
ALL
AML
allogeneic stem cell transplantation
acute myeloid leukemia
minimal residual disease
conditioning regimen
alternative donors
B-ALL
DUX4
IKZF1
PAX5
Ph-like
ZNF384
NUTM1
T-ALL
NOTCH1
BCL11B
transcriptome
genome
chronic myeloid leukemia
CML
tyrosine kinase inhibitor
immunizations
COVID-19
childhood acute lymphoblastic leukemia
low-risk ALL
risk-stratified treatment
treatment related toxicity
L-asparaginase
acute pancreatitis
polymorphism
SNV
ABCC4
CFTR
other extramedullary relapse
lymphoblastic leukemia
children
prognosis
evolution of CAR T cells
FDA-approved CAR products
TcR versus CAR
limitations and complications of CAR T cell therapy
future directions of CAR T cell therapy
n/a
thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general
thema EDItEUR::P Mathematics and Science::PN Chemistry
Sarrera elektronikoa:ONIX_20220621_9783036541679_133
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
Izan zaitez lehena ohar bat uzten!
Lehenik saioa ireki behar duzu

Antzeko izenburuak